Citation Impact
Citing Papers
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
2009
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Computational Thermostabilization of an Enzyme
2005 StandoutScienceNobel
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
2002 StandoutScienceNobel
The Molecular Biology of Cyclic Nucleotide Phosphodiesterases
1999
Natural engineering principles of electron tunnelling in biological oxidation–reduction
1999 StandoutNature
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Sequence similarity between dopamine β‐hydroxylase and peptide α‐amidating enzyme: Evidence for a conserved catalytic domain
1989
Carbon–heteroatom bond formation catalysed by organometallic complexes
2008 StandoutNature
Computational Enzyme Design
2013 StandoutNobel
Selenium-Based Antihypertensives
1998
Mechanism of inhibition of dopamine .beta.-monooxygenase by quinol and phenol derivatives, as determined by solvent and substrate deuterium isotope effects
1991
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease
2005
Inflammatory Bowel Disease
2009 Standout
A Self‐Sufficient Peroxide‐Driven Hydroxylation Biocatalyst
2003 StandoutNobel
Drugs for bad bugs: confronting the challenges of antibacterial discovery
2006 Standout
Electronic nature of the transition state for nucleoside hydrolase. A blueprint for inhibitor design
1993
Synthesis of a statistically exhaustive fluorescent peptide substrate library for profiling protease specificity
2000
Electron spin-echo studies of the copper(II) binding sites in dopamine .beta.-hydroxylase
1988
Design and Synthesis of Aryl Ether Inhibitors of the Bacillus Anthracis Enoyl‐ACP Reductase
2008
Catalytic C–H functionalization by metal carbenoid and nitrenoid insertion
2008 StandoutNature
The effect of the inactive mutation on longevity, sex, rhythm and resistance to p-Cresol in Drosophila melanogaster
1993
The Catalytic Asymmetric Abramov Reaction
2014 StandoutNobel
Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group
2004
Kemp elimination catalysts by computational enzyme design
2008 StandoutNatureNobel
Crystal structure of an HIV-binding recombinant fragment of human CD4
1990 StandoutNatureNobel
Rapid freeze and chemical-quench studies of dopamine .beta.-monooxygenase: comparison of pre-steady-state and steady-state parameters
1989
Enzymatic functionalization of carbon–hydrogen bonds
2010 StandoutNobel
Mature dendritic cells boost functionally superior CD8+ T-cell in humans without foreign helper epitopes
2000 StandoutNobel
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Urinary p-cresol in autism spectrum disorder
2012
Structural insights into Staphylococcus aureus enoyl‐ACP reductase (FabI), in complex with NADP and triclosan
2009
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Structure determination ofO-linked glycopeptides by tandem mass spectrometry
1990
Correlation of copper valency with product formation in single turnovers of dopamine .beta.-monooxygenase
1989
The Crystal Structure of Yeast Fatty Acid Synthase, a Cellular Machine with Eight Active Sites Working Together
2007 StandoutNobel
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Oxygen-18 kinetic isotope effects in the dopamine .beta.-monooxygenase reaction: Evidence for a new chemical mechanism in non-heme, metallomonooxygenase
1994
Complete Assignment of Disulfide Bonds in Bovine Dopamine .beta.-Hydroxylase
1994
Cross-crystal averaging reveals that the structure of the peptidyl-transferase center is the same in the 70S ribosome and the 50S subunit
2008 StandoutNobel
Finding the gems using genomic discovery: antibacterial drug discovery strategies – the successes and the challenges
2004
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Copper K-extended x-ray absorption fine structure studies of oxidized and reduced dopamine beta-hydroxylase. Confirmation of a sulfur ligand to copper(I) in the reduced enzyme.
1991
Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals.
1990 StandoutNobel
Energetics of the Catalytic Reaction of Ribonuclease A: A Computational Study of Alternative Mechanisms
1998 StandoutNobel
Cross‐Coupling Reactions on Azoles with Two and More Heteroatoms
2006
Oxygen Activation by the Noncoupled Binuclear Copper Site in Peptidylglycine α-Hydroxylating Monooxygenase. Reaction Mechanism and Role of the Noncoupled Nature of the Active Site
2004
A functionally split pathway for lysine synthesis in Corynebacterium glutamicium
1991
Multicopper Oxidases and Oxygenases
1996 Standout
A Proficient Enzyme
1995 Science
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
C-H Bond Functionalization in Complex Organic Synthesis
2006 StandoutScience
CELLULAR AND HUMORAL IMMUNE RESPONSES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AFTER VACCINATION WITH ANTIGEN PULSED DENDRITIC CELLS
1999
Protein and carbohydrate structural analysis of a recombinant soluble CD4 receptor by mass spectrometry
1989
Aptamers Selected for Higher-Affinity Binding Are Not More Specific for the Target Ligand
2006 StandoutNobel
Chiral 1,1′-Diphosphetanylferrocenes: New Ligands for Asymmetric Catalytic Hydrogenation of Itaconate Derivatives
2000
Preparation of peptidic α-hydroxy phosphonates a new class of transition state analog renin inhibitors
1990
Oxygen insertion in organic substrates catalyzed by copper compounds
1992
The Use of X-Ray Absorption Spectroscopy for Detection of Metal-Metal Interactions. Application to Copper-Containing Enzymes
1988
Synthesis and crystal structures of a series of amide copper(II ) complexes
1993
Expression of human dopamine β-hydroxylase in Drosophila Schneider 2 cells
1996
Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry
2005 Standout
Isolation of Fast Purine Nucleotide Synthase Ribozymes
2004
Carboxylate-Assisted Transition-Metal-Catalyzed C−H Bond Functionalizations: Mechanism and Scope
2011 Standout
Amino Acid Biosynthesis in the Halophilic Archaeon Haloarcula hispanica
1999 StandoutNobel
Catalytic Stereoselective Synthesis of Diverse Oxindoles and Spirooxindoles from Isatins
2012
An Orally Active Selenium-Based Antihypertensive Agent with Restricted CNS Permeability
1997
Use of isotope effects to characterize intermediates in mechanism-based inactivation of dopamine beta-monooxygenase by beta-chlorophenethylamine.
1990
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Aryl−Aryl Bond Formation by Transition-Metal-Catalyzed Direct Arylation
2007 Standout
Rapid synthesis of α-ketoamides using microwave irradiation–simultaneous cooling method
2003
Model monooxygenase reactivity by binuclear two-coordinate copper(I) complexes extends to new ligand systems containing nitrogen and sulphur donors
1991
Nucleoside hydrolase from Crithidia fasciculata. Metabolic role, purification, specificity, and kinetic mechanism.
1991
Structure-based discovery of β 2 -adrenergic receptor ligands
2009 StandoutNobel
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Activation of C−H Bonds by Metal Complexes
1997 Standout
Mechanisms Whereby Mononuclear Copper Proteins Functionalize Organic Substrates
1996 Standout
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Catalytic Mechanism and Performance of Computationally Designed Enzymes for Kemp Elimination
2008 StandoutNobel
Electrostatic Basis for Enzyme Catalysis
2006 StandoutNobel
Computer simulations of enzyme catalysis: Finding out what has been optimized by evolution
1998 StandoutNobel
The Halogen Bond
2016 Standout
Characterization of a carbon monoxide complex of reduced dopamine beta-hydroxylase. Evidence for inequivalence of the Cu(I) centers.
1990
Protein Radicals in Enzyme Catalysis
1998 Standout
The Mating of a Fly
1994 StandoutScienceNobel
ENZYMATIC TRANSITION STATES AND TRANSITION STATE ANALOG DESIGN
1998
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
Copper monooxygenase models: hydroxylation reactions resulting from dioxygen activation by copper(I ) complexes
1992
Active site labeling of dopamine beta-hydroxylase by two mechanism-based inhibitors: 6-hydroxybenzofuran and phenylhydrazine.
1990
Purification and characterization of catalytic fragments of phosphorylase kinase gamma subunit missing a calmodulin-binding domain.
1990 StandoutNobel
Palladium-Catalyzed Ligand-Directed C−H Functionalization Reactions
2010 Standout
Challenges of Antibacterial Discovery
2011
Impact of scaffold rigidity on the design and evolution of an artificial Diels-Alderase
2014 StandoutNobel
About Supramolecular Assemblies of π-Conjugated Systems
2005 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Works of Walter E. DeWolf being referenced
A substrate combinatorial array for caspases
1999
Bovine dopamine .beta.-hydroxylase, primary structure determined by cDNA cloning and amino acid sequencing
1990
The copper sites of dopamine .beta.-hydroxylase: an x-ray absorption spectroscopic study
1988
TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells
1999
.beta.-Substituted phenethylamines as high-affinity mechanism-based inhibitors of dopamine .beta.-hydroxylase
1988
Inactivation of dopamine .beta.-hydroxylase by p-cresol: isolation and characterization of covalently modified active site peptides
1988
Role of Conserved Histidines in Catalytic Activity and Inhibitor Binding of Human Recombinant Phosphodiesterase 4A
1997
Endothelin-Converting Enzyme: Substrate Specificity and Inhibition by Novel Analogs of Phosphoramidon
1996
Inactivation of dopamine .beta.-hydroxylase by .beta.-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide
1989
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)
2001
Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents
2001
Mechanism-based inactivation of dopamine .beta.-hydroxylase by p-cresol and related alkylphenols
1987
Studies on the active site of succinyl-CoA:tetrahydrodipicolinate N-succinyltransferase. Characterization using analogs of tetrahydrodipicolinate.
1986
Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK
2003
Design and kinetic characterization of multisubstrate inhibitors of dopamine .beta.-hydroxylase
1986
Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates ofStaphylococcus aureus
2002
Renal cell carcinoma: recent progress and future directions.
1997
Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7
2001
Multisubstrate inhibitors of dopamine .beta.-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site
1987
Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)
2002
Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine .beta.-hydroxylase
1986
The catalytic site of AMP nucleosidase. Substrate specificity and pH effects with AMP and formycin 5'-PO4.
1979
Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
1988
Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK)
2003
AMP nucleosidase: kinetic mechanism and thermodynamics
1986